Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis
- PMID: 28261676
- PMCID: PMC5330375
- DOI: 10.4111/icu.2017.58.2.82
Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis
Abstract
Purpose: To determine the efficacy of phosphodiesterase type 5 inhibitors (PDE5i) as medical expulsive therapy (MET) for the treatment of distal ureteral calculi.
Materials and methods: A search strategy was conducted in the MEDLINE, CENTRAL, and Embase databases. Searches were also conducted in other databases and unpublished literature. Clinical trials were included without language restrictions. The risk of bias was evaluated with the Cochrane Collaboration's tool. An analysis of random effects due to statistical heterogeneity was conducted. The primary outcome was the expulsion rate of the distal ureteral calculus in 28 days. The secondary outcomes were the time to expulsion, side effects of treatment, and amount (mg) of nonopioid analgesia. The measure of the effect was the risk difference (RD) with a 95% confidence interval (CI). The planned interventions were PDE5i vs. placebo, tadalafil vs. placebo, and tadalafil vs. tamsulosin.
Results: Four articles were included in the qualitative and quantitative analysis. Records of 580 patients were found among the four studies. A low risk of bias was shown for the majority of the study items. The calculi expulsion rate had an RD of 0.26 (95% CI, 0.15-0.37) and a less prolonged expulsion as a secondary outcome with a mean difference of -4.39 days (95% CI, -6.69 to -2.09) in favor of PDE5i compared with the placebo. No significant difference was found for these outcomes when comparing tadalafil with tamsulosin.
Conclusions: Compared with a placebo, PDE5i could be effective as MET for the treatment of distal ureter calculi.
Keywords: Meta-analysis; Phosphodiesterase 5 inhibitors; Review; Ureteral calculi.
Conflict of interest statement
CONFLICTS OF INTEREST: The authors have nothing to disclose.
Figures




Similar articles
-
Efficacy and safety of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi of 5 to 10 mm in size: A systematic review and network meta-analysis.Kaohsiung J Med Sci. 2019 May;35(5):257-264. doi: 10.1002/kjm2.12048. Epub 2019 Mar 21. Kaohsiung J Med Sci. 2019. PMID: 30897293 Free PMC article.
-
Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis.PLoS One. 2015 Aug 5;10(8):e0134589. doi: 10.1371/journal.pone.0134589. eCollection 2015. PLoS One. 2015. PMID: 26244843 Free PMC article.
-
Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis.Br J Clin Pharmacol. 2016 Jan;81(1):13-22. doi: 10.1111/bcp.12737. Epub 2015 Sep 21. Br J Clin Pharmacol. 2016. PMID: 26255996 Free PMC article.
-
Is silodosin better than tadalafil as a medical expulsive therapy in lower ureter stones?Arch Ital Urol Androl. 2025 Jun 30;97(2):13642. doi: 10.4081/aiua.2025.13642. Epub 2025 Apr 17. Arch Ital Urol Androl. 2025. PMID: 40247733
-
Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.J Endourol. 2017 May;31(5):427-437. doi: 10.1089/end.2016.0486. Epub 2017 Mar 17. J Endourol. 2017. PMID: 28306333
Cited by
-
Efficacy of mirabegron for ureteral stones: a systematic review with meta-analysis of randomized controlled trials.Front Pharmacol. 2023 Dec 20;14:1326600. doi: 10.3389/fphar.2023.1326600. eCollection 2023. Front Pharmacol. 2023. PMID: 38178860 Free PMC article.
-
Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as Medical Expulsive Therapy for Lower Ureteric Stones: A Randomized Controlled Trial.Adv Urol. 2020 Jan 29;2020:4347598. doi: 10.1155/2020/4347598. eCollection 2020. Adv Urol. 2020. PMID: 32411212 Free PMC article.
-
Meta-analysis of the efficacy of sexual intercourse for distal ureteric stones.J Int Med Res. 2019 Feb;47(2):497-504. doi: 10.1177/0300060518814116. Epub 2019 Jan 9. J Int Med Res. 2019. PMID: 30621491 Free PMC article.
-
Role of phosphodiesterase inhibitors in stent-related symptoms: a systematic review and meta-analysis.World J Urol. 2020 Apr;38(4):929-938. doi: 10.1007/s00345-019-02862-z. Epub 2019 Jun 28. World J Urol. 2020. PMID: 31254098
-
Efficacy and safety of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi of 5 to 10 mm in size: A systematic review and network meta-analysis.Kaohsiung J Med Sci. 2019 May;35(5):257-264. doi: 10.1002/kjm2.12048. Epub 2019 Mar 21. Kaohsiung J Med Sci. 2019. PMID: 30897293 Free PMC article.
References
-
- Colella J, Kochis E, Galli B, Munver R. Urolithiasis/nephrolithiasis: what's it all about? Urol Nurs. 2005;25:427–428. 475, 449. - PubMed
-
- Wooldridge AA, Seahorn TL, Williams J, Taylor HW, Oliver JL, Kim DY, et al. Chronic renal failure associated with nephrolithiasis, ureterolithiasis, and renal dysplasia in a 2-year-old quarter horse gelding. Vet Radiol Ultrasound. 1999;40:361–364. - PubMed
-
- Miller OF, Kane CJ. Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol. 1999;162(3 Pt 1):688–690. - PubMed
-
- Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol. 2005;174:167–172. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous